BioNanofluidics for Drug Screening, Disease Diagnosis, Medical - PowerPoint PPT Presentation

Nov 25, 2023 •751 likes •821 views

BioNanofluidics for Drug Screening, Disease Diagnosis, Medical Device Design, and Personalized Medicine Yaling Liu Professor 09/15/2020 Brief Bio of Yaling Liu ASME Fellow, Associate editor of Journal of Medical Device Education

BioNanofluidics for Drug Screening, Disease Diagnosis, Medical Device Design, and Personalized Medicine Yaling Liu Professor 09/15/2020
Brief Bio of Yaling Liu • ASME Fellow, Associate editor of Journal of Medical Device • Education Northwestern University, Department of Mechanical Engineering, PhD 2006 • key publications 1. S. Wang, Y. Zhou, X. Qin, S. Nair, X. Huang, Y. Liu, “Label Free Detection of Rare Circulating Tumor Cells by Image Analysis and Machine Learning”, Scientific Report, in press, 2020 2. M. Razizadeh, M. Nikfar, R. Paul, Y. Liu, “Coarse-Grained Modeling of Pore Formation, Growth, and Reseal on the Red Blood Cell Membrane Under Large Dynamic Deformations”, Biophysical Journal, 119 (3): 471-482, 2020 3. C. Uhl, W. Shi, Y. Liu, “Microfluidic Device for Expedited Tumor Growth Towards Drug Evaluation” Lab on a Chip, 19, 1458-1470, 2019 4. W. Shi, S. Wang, A. Maarouf, R. He, Y. Doruk, Y. Liu, "Magnetic Particles Assisted Capture and Release of Rare Tumor Cells using Wavy-herringbone Structured Microfluidic Devices", Lab on a Chip, 17, 3291-3299, 2017 • Keywords for research Biotransport, Microfluidics, Nanomedicine, Cell Mechanics, MEMS, NEMS
Biomimetic Drug Evaluation Platform Nanoparticle binding on biomimetic blood vessel We developed cell-seeded microfluidic chips for endothelium coated to mimic blood vessel evaluation of various nanoparticles drug carriers Binding distribution of ICAM-1 coated 210nm fluorescence Real-time particle binding Vascular Permeability nanoparticle on anti-ICAM-1 coated microfluidic channels study under flow dynamics
Cancer Diagnosis and Personalized Medicine A CTC from MM-05 In collaboration with Lehigh Valley A WBC from MM-05 Hospital, we are using liquid biopsy A CTC from (circulating tumor RCC-06 cell and circulating Lab on Chip Capture of Circulating Tumor Cell from Patient Blood Sample tumor DNA) for cancer diagnosis, monitoring, and personalized drug screening 3D culturing of tumor spheroid for personalized drug testing
Hemolysis Prediction in Medical Devices Multiscale modeling of blood cell damage in medical device Hemolysis evaluation is an important step for FDA approval of any blood-wetting device. In collaboration with University of Maryland Medical School, we aim to develop a cellular model that can predict hemolysis in any device.
Contact  Looking for PhD student and Post Doc  Our research is supported by National Institute of Health (NIH)  National Science Foundation (NSF)   Contact: yal310@lehigh.edu

Recommend

Choosing the Right 1. Diagnosis screening 2. Staging of disease Treatment Regimen 3.

2/25/2019 What is the role of primary care in HCV management? Choosing the Right 1. Diagnosis screening 2. Staging of disease Treatment Regimen 3. Preventing progression 4. Treatment! Hemant Shah MD MScCH HPTE 5. Follow-up after

228 views • 5 slides

Objectives of Congenital Heart Disease Prenatal Diagnosis of Critical Recognize the importance

Keeping the Beat: Pediatric Cardiac Screening and Management Objectives of Congenital Heart Disease Prenatal Diagnosis of Critical Recognize the importance of screening for Critical Congenital Heart Disease Congenital Heart Defects (CCHD)

364 views • 9 slides

Outlines Drug discovery HTS Screening Computational Screening Structure-based

Modeling HTS Screening for Drug discovery Ying-Ta Wu Genomics Research Center, Academia Sinica, Taiwan. e-mail: ywu@gate.sinica.edu.tw Outlines Drug discovery HTS Screening Computational Screening Structure-based approach

803 views • 37 slides

CANCER SCREENING AND DIAGNOSIS D R M A T T N O R M A N G P P A R T N E R , T H E B E L L S

CANCER SCREENING AND DIAGNOSIS D R M A T T N O R M A N G P P A R T N E R , T H E B E L L S U R G E R Y P R A C T I C E C A N C E R C H A M P I O N Patient Participation Group Presentation 21 September 2020 TODAYS TALK Exist istin

242 views • 21 slides

Chemspace Phenotypic Screening Set Description Phenotypic screening (PS) is one of the two major

Chemspace Phenotypic Screening Set Description Phenotypic screening (PS) is one of the two major approaches at early stage drug discovery projects, apart from the target-based screens. PS is focused on the overall effect a drug molecule causes

337 views • 6 slides

Artificial Intelligence PESTOZ Crop Disease Diagnosis PESTOZ Crop Disease Diagnosis

Empowering Farmers with Empowering agriculture with Artificial Intelligence! Artificial Intelligence PESTOZ Crop Disease Diagnosis PESTOZ Crop Disease Diagnosis Infected crop found Click photo & Identify disease Get your Upload on

355 views • 9 slides

Hallmarks of Alzheimers disease Clinical features and diagnosis of Alzheimers disease

Hallmarks of Alzheimers disease Clinical features and diagnosis of Alzheimers disease Early onset: APP , PSEN1 , PSEN2 Progressive, unremitting neurodegenerative disease Dementia which leads to difficulty with daily life

471 views • 9 slides

Drug screening against Yellow fever Virus Lucio Freitas Junior Departamento de

Drug screening against Yellow fever Virus Lucio Freitas Junior Departamento de Micorbiologia Instituto de Cincias Biomdicas Universidade de So Paulo The Phenotypic Screening Platform at ICB-USP Chemical and Genetic screening

289 views • 18 slides

Infectious Disease Screening and Testing for Donors of HCT/Ps FDA-ISCT Liaison Meeting October

Infectious Disease Screening and Testing for Donors of HCT/Ps FDA-ISCT Liaison Meeting October 19, 2016 Overview Relevant Communicable Disease Agents and Diseases (RCDADs) WNV screening and testing ZIKV screening and testing 2

851 views • 22 slides

Educational Objectives Discuss the importance of screening and surveillance of HCC and the

Educational Objectives Discuss the importance of screening and surveillance of HCC and the importance of early disease diagnosis Review the currently available treatment algorithms and the role of multiple disciplines in the management

752 views • 49 slides

Screening Screening By: Michael OReilly Technical Advisor FETP Thailand Session Objectives

Screening Screening By: Michael OReilly Technical Advisor FETP Thailand Session Objectives Session Objectives Distinguish screening from diagnosis Distinguish screening from diagnosis Understand the basic principles of

520 views • 40 slides

Diabetic Eye Screening Extended Screening Intervals Public Health England leads the NHS Screening

Diabetic Eye Screening Extended Screening Intervals Public Health England leads the NHS Screening Programmes Screening The process of identifying healthy people who may be at increased risk of an important / significant disease or condition.

497 views • 13 slides

Residential Turfgrass Plant Pathology review, diagnosis, disease Disease Diagnostics Update

Objectives for today Residential Turfgrass Plant Pathology review, diagnosis, disease Disease Diagnostics Update on what diseases we have been seeing in the plant disease clinic on lawn grass samples Diagnostic tips and tricks for common

384 views • 10 slides

1 Differential Diagnosis March 14, 2019 Diagnosis is the identification of the

1 Differential Diagnosis March 14, 2019 Diagnosis is the identification of the nature and cause of a certain phenomenon di ff erential diagnosis is the distinguishing of a particular disease or condition from others that

1.12k views • 51 slides

1. Research Motivation Genetic Analysis for Disease: occurrence, diagnosis and treatment

1. Research Motivation Genetic Analysis for Disease: occurrence, diagnosis and treatment Data-driven Disease-Gene Association Prediction: Curated Databases limited knowledge within established frameworks Literature Based Discovery

390 views • 21 slides

Challenges in the Diagnosis of Interstitial Lung Disease New Classification of IIP Prior

5/12/2014 Overview Challenges in the Diagnosis of Interstitial Lung Disease New Classification of IIP Prior classification Modifications for new classification Diagnosis of UIP/NSIP Clinical, radiologic, pathologic findings

190 views • 15 slides

Challenges in the Diagnosis of Interstitial Lung Disease New Classification of IIP Prior

5/24/2014 Overview Challenges in the Diagnosis of Interstitial Lung Disease New Classification of IIP Prior classification Modifications for new classification Diagnosis of UIP/NSIP Clinical, radiologic, pathologic findings

166 views • 16 slides

Problem -based Scenarios in Practice E-learning for plant disease diagnosis Problem-based

Problem -based Scenarios in Practice E-learning for plant disease diagnosis Problem-based Scenarios for Plant Disease Diagnosis The why? Diagnosis is more than just identification of a suspected causal agent The diagnostician:

517 views • 25 slides

Perspectives from Families on Screening, Diagnosis, and Support Lynda Gargan, Ph.D., Executive

Mental Health and Chil ildren: Perspectives Mental Health and Children: from Families on Screening, g, Evaluation and Dia iagnosis Perspectives from Families on Screening, Diagnosis, and Support Lynda Gargan, Ph.D., Executive Director

593 views • 27 slides

Diagnosis of Cutaneous SCC D R V H O G A R T H D E R M A T O L O G Y C O N S U L T A N T K I

Diagnosis of Cutaneous SCC D R V H O G A R T H D E R M A T O L O G Y C O N S U L T A N T K I N G S T O N H O S P I T A L INTRODUCTION Aim : Increased confidence screening for SCC Encourage follow up care in the community especially

622 views • 30 slides

Interstitial lung disease: diagnosis and testing Professor Joanna Porter, Consultant in

RCGP accredited until 1 st April 2020 RCN accredited until 2 nd July 2020 Accreditation applies only to the educational content and not to any product RCN cannot confirm competence of any practitioner Interstitial lung disease: diagnosis and

320 views • 12 slides

Post mortem investigation of Inherited Metabolic Disease - the last opportunity for a diagnosis -

Post mortem investigation of Inherited Metabolic Disease - the last opportunity for a diagnosis - Dr Simon Olpin Lead Clinical Scientist in Inherited Metabolic Disease Sheffield Childrens Hospital SIDS/SUDI

719 views • 59 slides

60/20 program Screening for renal disease in individuals Age 40-65 With Diabetes

60/20 program Screening for renal disease in individuals Age 40-65 With Diabetes Hypertension Cardiovascular disease Obesity Family history of ESRD 60/20 program eGFR <60 Implementation of renal and cardiovascular

361 views • 7 slides

Urinary antihypertensive drug metabolite screening using molecular networking coupled to

Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentation Justin J. J. van der Hooft Sandosh Padmanabhan Karl E. V. Burgess Michael P. Barrett (2016).

492 views • 16 slides